Start-Ups to Watch
Minovia Therapeutics and the Mighty Mitochondria
An Israel-based start-up is taking on a cellular-level challenge that is somehow both elusive and ubiquitous at the same time.
Welcome to MyStrategist, the digital home for MedTech Strategist.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Start-Ups
VahatiCor: On the Trail of Microvascular Disease
Coronary microvascular disease can contribute to major cardiovascular pathology, but there are no approved disease-modifying therapies. On the hunt for a new solution, VahatiCor is pursuing a new device that narrows coronary sinus flow to improve perfusion in the microvascular network.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Start-Ups
GI Start-Ups Replace Gut Instincts With Precision Data
We profile three MedTech Innovator accelerator companies using implanted and other devices to gather information once accessible by endoscopy only: Cyted Health, Gravitas Medical, and Plio Surgical.